- Report
- May 2025
- 186 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- November 2024
- 150 Pages
Global
From €5329EUR$5,950USD£4,543GBP
- Report
- June 2025
- 152 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- January 2025
- 175 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- December 2024
- 150 Pages
Global
From €2911EUR$3,250USD£2,481GBP
€4344EUR$4,850USD£3,703GBP
- Report
- April 2025
- 175 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- February 2025
- 182 Pages
Global
From €3426EUR$3,825USD£2,920GBP
€4031EUR$4,500USD£3,436GBP
- Report
- May 2025
- 560 Pages
Global
From €4434EUR$4,950USD£3,779GBP
- Report
- January 2025
- 165 Pages
Global
From €4165EUR$4,650USD£3,550GBP
- Report
- May 2025
- 194 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- January 2025
- 165 Pages
Global
From €2553EUR$2,850USD£2,176GBP
- Report
- May 2025
- 183 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 183 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 199 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 187 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- April 2025
- 138 Pages
Global
From €2686EUR$2,999USD£2,290GBP
- Report
- February 2025
- 135 Pages
Global
From €2686EUR$2,999USD£2,290GBP
- Report
- August 2024
- 143 Pages
Global
From €2686EUR$2,999USD£2,290GBP
- Report
- November 2024
- 120 Pages
Global
From €5329EUR$5,950USD£4,543GBP
- Report
- September 2024
- 120 Pages
Global
From €5329EUR$5,950USD£4,543GBP

A diagnostic biomarker is a biological molecule or gene that is used to identify a particular disease or condition. It is used to diagnose, monitor, and predict the progression of a disease or condition. Diagnostic biomarkers are used to detect the presence of a disease or condition, to determine the severity of the disease or condition, and to monitor the effectiveness of treatments. Diagnostic biomarkers are used in a variety of medical fields, including oncology, neurology, cardiology, and infectious diseases.
Diagnostic biomarkers are typically identified through a variety of methods, including genetic sequencing, proteomics, and metabolomics. These methods allow for the identification of biomarkers that are specific to a particular disease or condition.
The diagnostic biomarker market is a rapidly growing field, with many companies developing and marketing diagnostic biomarkers. Companies in this market include Illumina, Thermo Fisher Scientific, Qiagen, Roche, and Agilent Technologies. Show Less Read more